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The aim of the present study was to determine whether acetazolamide (AZ)
contributes to the inhibition of the fast inactivating transient K+ current (IA)i n
adult rat nodose ganglion (NG) neurons. We have previously shown that pre-
treatment with either AZ or 4-AP attenuated or blocked the CO2-induced in-
hibition of slowly adapting pulmonary stretch receptors in in vivo experiments.
The patch-clamp experiments were performed by using the isolated NG neu-
rons. In addition to this, the RT-PCR of mRNA and the expression of voltage-
gated K+ (Kv) 1.4, Kv 4.1, Kv 4.2, and Kv 4.3 channel proteins from nodose
ganglia were examined. We used NG neurons sensitive to the 1 mM AZ appli-
cation. The application of 1 mM AZ inhibited the IA by approximately 27% and
the additional application of 4-AP (1 mM) further inhibited IA by 48%. The ap-
plication of 0.1 μM α-dendrotoxin (α-DTX), a slow inactivating transient K+
current (ID) blocker, inhibited the baseline IA by approximately 27%, and the
additional application of 1 mM AZ further decreased the IA by 51%. In current
clamp experiments, AZ application (1 mM) increased the number of action
potentials due to the decreased duration of the depolarizing phase of action
potentials and/or due to a reduction in the resting membrane potential. Four
voltage-gated K+ channel proteins were present, and most (80–90%) of the
four Kv channels immunoreactive neurons showed the co-expression of car-
bonic anhydrase-II (CA-II) immunoreactivity. These results indicate that the
application of AZ causes the reduction in IA via the inhibition of four voltage-
gated K+ channel (Kv) proteins without affecting ID.
Introduction
Enzymatic dispersion of the ganglia separates the neu-
ronal soma from its axons, and as a result, the patch-
clamp study has been used to investigate the electrophy-
siological properties of neurons without intact afferent
ﬁbers. Nodose ganglia neurons innervate a variety of tis-
sues including the pulmonary, cardiovascular, and gas-
trointestinal afferent inputs. In conventional intracellu-
lar recording techniques using NG neurons, 90% of them
have unmyelinated axons and the remaining neurons
have myelinated axons [1,2]. Based on the analysis of
neurons possessing the conduction velocity (CV, m/s)
and action potential (AC) duration (ms) by using slices
of nodose ganglia with intact vagal axons, Li and Schild
[3] identiﬁed two types of myelinated afferent ﬁbers: one
group (10/76, 13%) exhibited CVs in excess of 10 m/s
with narrow (<1 ms) AC duration while the another
group (9/76, 12%) had CVs as low as 4 m/s with broad
AC (>2 ms), and the remaining neurons (57/75, 75%)
were identiﬁed as unmyelinated afferent ﬁbers with ei-
ther CVs less than 1 m/s or an AC duration of over
2 ms. The SARs are known to be mechanoreceptors that
slowly adapt to a varying mechanical stimulus. It has
been reported that the CO2-induced inhibition of SARs
is blocked or attenuated by the administration of either
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acetazolamide (AZ), a carbonic anhydrase inhibitor, or
4-AP (a K+ channel blocker) in in vivo experiments us-
ing rabbits [4,5] and rats [6,7]. When considering these
results, taken together, it seems likely that NG neurons
responding to AZ may be useful to investigate the physi-
ological properties of the soma of SARs.
There are many observations on the electrophysiolog-
ical properties of NG neurons [8–11]. For example, sev-
eral voltage-gated K+ (Kv) channels have the ability to
regulate the action potential shape, adaptation, and ex-
citability of sensory neurons. The fast inactivating K+
(A-type) current (IA) in NG is known to be inhibited
by the application of 4-AP at the concentration range
o f1t o3 0μM [12]. Such a current is also involved
in a slow inactivating transient K+ current (ID)s e n s i -
tive to lower concentrations of α-dendrotoxin (α-DTX)
and 4-AP [13–15]. Furthermore, there is a report stat-
ing that after the loss of ID due to 0.1 μM α-DTX ap-
plication, the additional application of 0.5 mM 4-AP still
modulates the properties of the action potential number
and shape in adult rat small-diameter trigeminal ganglion
(TG) neurons, indicating that the ID is a component of
the IA [16]. In the isolated guinea-pig trachea/bronchus
preparation using NG-derived vagal afferent ﬁber hav-
ing mechanically sensitive receptive ﬁelds, the applica-
tion of either 1 mM 4-AP or 1 μM α-DTX could elicit
spontaneous action potentials but neither tetraethylam-
monium (TEA), iberiotoxin, glybenclamide, 5,8,11,14-
eicosatetreyonic acid (ETYA), BDS-II, nor apamin caused
action potential generation [17]. In addition, there are no
reports to examine whether AZ inﬂuences 4-AP-sensitive
K+ currents involving IA and/or ID in adult rat NG neu-
rons. There is evidence that the elctrophysiological prop-
erties of the membranes of soma in primary afferent neu-
rons are similar to those of peripheral terminals in the
same neurons [18].
The purposes of the present study were designed to
evaluate to what extent AZ inhibits IA without and with
the loss of ID and how the responses of action potential
properties are altered by the application of AZ before and
after pretreatment with 4-AP in adult rat NG neurons.
To determine whether homogenetic Kv 1.4 channels are
predominant on NG neurons, the expression of A-type
K+ channel proteins such as Kv 1.4 and the Kv 4 fam-
ily (Kv 4.1, Kv 4.2, and Kv 4.3) was examined by means
of reverse transcription–polymerase chain reaction (RT-
PCR) analysis. Furthermore, we also examined whether
CA-II-immunoreactive cells are actually co-expressed in
NG neurons that express immunoreactivities for Kv 1.4
and the Kv 4 family (Kv 4.1–4.3). Our data support the
idea that the reduced IA following the 1 mM AZ applica-
tion would occur as a result of the combined inhibition of
Kv 1.4 and Kv 4.1–4.3 channels.
Materials and Methods
All animal studies were approved by the Guide for the Care
and Use of Laboratory Animals published by the U.S. Na-
tional Institutes of Health (NIH Publication No. 85–23, re-
vised 1996). In addition, all experimental protocols used
in this study were approved by the Animal Use and Care
Committee of Nippon Dental University. We minimized
the number of animals used and their suffering.
Cell Culture
Primary cultures of dissociated adult male rat NG neu-
rons were prepared as described previously [18–21]. Wis-
tar rats (200–300 g) were deeply anesthetized with pen-
tobarbital sodium (50–60 mg/kg, i.p.). The nodose ganglia
were identiﬁed, dissected from the vagus nerve trunks
and placed in modiﬁed Hank’s balanced solution (HBSS)
containing (in mM) 130 NaCl, 5 KCl, 0.3 KH2PO4,4
NaHCO3,0 . 3N a 2HPO4, 5.6 glucose, and 10 HEPES. The
dissected nodose ganglia were transferred to HBSS con-
taining collagenase types XI (1.5 mg/mL: Sigma-Aldrich,
St. Louis, MD, USA) and II (1.5 mg/mL, Sigma-Aldrich).
The cells were triturated with a ﬁre-polished Pasteur
pipette and subsequently were plated onto the cover
slips pretreated with Poly-L-lysine in a 35-mm dish.
The planting medium contained a Leibovitz’s L-15 solu-
tion (Invitrogen Corp., Carlsbad, CA, USA) supplemented
with 10% newborn calf serum, 50 U/mL penicillin-
streptomycin (Invitrogen Corp.), 26 mM NaHCO3,a n d
10 mM glucose. The cells were recorded within 2 to 10 h
following plating. Neurons were accepted for study only if
they showed a stable resting membrane potential exceed-
ing −45 mV and an action potential overshoot of more
than +30 mV.
Electrophysiology
Whole-cell patch-clamp recordings were performed at
room temperature (22–25◦C). The current was measured
with an ampliﬁer (Axopatch-1D; Axon Instruments Inc.,
Union City, CA, USA). The pipette resistance was 2 to
4M  . After the pipette was ﬁlled with a recording solu-
tion, currents and voltages were low-pass ﬁltered at 5 to
10 kHz with a four-pole Bessel ﬁlter and digitally sampled
at 25 to 100 kHz. After seal formation and membrane dis-
ruption, capacity transients (31–38 pF) were cancelled.
The electrode access resistance (7–10 M ) also showed
compensations within 80–90%. Data obtained from the
neurons in which uncompensated series resistance re-
sulted in voltage-clamp errors of >5 mV did not un-
dergo any further analysis. No corrections were made
for liquid junction potentials before recording and this
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potential was calculated to be 6 mV. The whole-cell leak
current produced by the 10 mV depolarizing step pulse
was normally less than 10 pA. Isolated cells on a glass
cover slip dish were placed in a recording chamber (vol-
ume, 0.5 mL) and visualized under the phase contrast
of an inverted microscope (Nikon, Tokyo, Japan). The
chamber was perfused under gravity with a standard ex-
ternal solution of approximately 0.5 mL/min. The drugs
dissolved into the external solution were administered via
a linear array of seven super fusion polyethylene tubes
(280 μm in diameter) positioned close to the cell bodies
(approximately 200 μm).
I-Clamp
Current injections for 300 ms were applied in increments
of 50 pA. Action potentials were initially evoked by a de-
polarizing pulse at one threshold (1 T); the action poten-
tial number was measured during 3 times T (3 T). We
classiﬁed NG neurons as slowly adapting (SA)-type NG
neurons, as described in previous studies [22–24]. Dur-
ing current injection at 3T, we determined whether AZ
has 4-AP-like effects on the action potential in NG neu-
rons showing multiple action potentials of more than two
spikes. In some experiments, changes in action potential
characteristics [ﬁring frequency, resting membrane po-
tential (RMP), duration of half-amplitude of action po-
tential, duration of the depolarization phase of the action
potential (DDP), duration of the repolarization phase of
the action potential (DRP)] in response to current injec-
tions at 3 T were examined before and after the appli-
cation of AZ or 4-AP as well as during their combined
applications.
V-Clamp
The K+ currents were recorded from NG neurons (soma
diameter <35 μm). We further distinguished a transient
K+ current (IA) from a sustained K+ current (IK)a n d
the total outward K+ current by using the same steps
described in previous studies [11,16,17,25–27]. Outward
K+ currents were identiﬁed by applying a conditioning
pulse of either −40 or −120 mV from a holding potential
of −80 mV; then, the membrane was depolarized from
−40 or −120 mV to +60 mV in increments of 10 mV,
and +60 mV produced the largest peak in each record-
ing. The IA was determined by subtracting the −40 mV
protocol from the −120 mV protocol. Activation of the
currents was rapid and only partially delayed during the
200-ms depolarization pulse. In some experiments, 4-AP,
α-DTX, and AZ were used to determine whether AZ has
4-AP-like effects on K+ currents. Before recordings the
K+ currents, we initially conﬁrmed that the NG neurons
used in this study were sensitive to 1 mM AZ application,
by using I-clamp techniques as described above. In order
to measure the K+ currents, replacement of the external
solution was performed for 7–8 min.
Solutions
The external solution for the current clamp experiment
of the action potential contained 160 mM NaCl, 5 mM
KCl, 10 mM HEPES, 1 mM MgCl2,2m MC a C l 2,a n d
10 mM glucose; pH adjusted to 7.4 with NaOH. The in-
ternal solution contained 140 mM KCl, 10 mM HEPES,
10 mM EGTA, 1 mM CaCl2, 2 mM Mg-ATP, and 14 mM
Na2 creatine phosphate; the pH was adjusted to 7.3 with
KOH. For the voltage clamp experiment of the voltage-
dependent K+ current, the external solution contained
160 mM N-methyl D-glucamine (NMDG), 5 mM KCl,
10 mM HEPES, 1 mM MgCl2, and 10 mM glucose; the
pH was adjusted to 7.4 with KOH, and the internal so-
lution was the same as that used for the current clamp
experiments. The estimation of the free Ca2+ concen-
tration ranged from 10 to 100 nM in the internal solu-
tion that had both EGTA (10 mM) and CaCl2 (1 mM).
That concentration was the normal Ca2+ for sensory neu-
rons. Under such conditions of EGTA and CaCl2, voltage-
gated Ca2+ currents were successfully recorded in small-
diameter TG neurons from neonatal rats [28].
Drugs
All drugs (stock solutions) were stored at −20◦Ca n d
dissolved in the external solution. AZ (Sanwa Kagaku
Kenkyusho Co. Ltd., Nagoya, Japan, 500 mg) was di-
luted with 0.9% NaCl solution (20 mg/mL). AZ, a CA
inhibitor (0.01–10 mM), 4-AP, an IA blocker (1 mM;
Sigma-Aldrich); and α-DTX, an ID blocker (0.1 μM,
Alomone Labs, Jerusalem, Israel) were added to the per-
fusion. Maren et al. [29] demonstrated that concentra-
tions greater than 10−4 M, corresponding to 20 mg/kg in
in vivo experiments, have a nonspeciﬁc effect. We used
1 mM AZ, which is nearly equal to the calculated value
(20 mg/kg), as used in in vivo experiments. The molecu-
lar weight for AZ is 222.25 g. Assuming the total blood
volume of a rat is about 6.5 mL/100 g [30] would be be-
tween 13 and 19.5 mL of total blood diluting 4–6 mg per
200–300 g rat, respectively. These calculations are that
20 mg/kg of AZ would be closer to 1.3 mM. Therefore,
we examined lower and higher concentrations of 1 mM
AZ.
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Statistical Analysis
In voltage clamp experiments, the effects of test agents
(4-AP, 4-AP+AZ, α-DTX, and α-DTX+AZ) were calcu-
lated as the changes in the current density–voltage curve.
In current clamp experiments, the changes in the action
potential properties were examined before and after AZ
in the absence and presence of 4-AP. Statistical analyses
of physiological studies were performed using a paired
t-test and/or a repeated measure ANOVA with Tukey’s
post hoc test for paired samples. In addition, the group
comparisons of mean values (4-AP only vs. AZ+4-AP;
α-DTX only vs. α-DTX+AZ) were performed using Stu-
dent’s unpaired t-test. P values of less than 0.05 were
considered statistically signiﬁcant.
Kv Channel Protein
Total RNA was isolated from the whole nodose gan-
glia of six adult rats (240–300 g) with a Perfect RNA
Eukaryotic kit (Expender, Germany) as described in a
previous study [31]. Total RNA was treated with DNase
I (Invitrogen Corp.) at room temperature for 15 min to
remove any contaminating genomic DNA. The enzyme
was removed by a phenol-chloroform extraction. With
the use of the optical density reading, the total RNA
puriﬁcation was conﬁrmed to yield an A260 A280−1
ratio of 1.9–2.0. The RT-PCR was conducted with the
RT Applied Biosystems Kit (Applied Biosystems, Chiba,
Japan). The primers used for the Kv 1.4, Kv 4.1–4.3, and
GAPDH were 5 -GAAAACGAACAGACCCAGC-3  and 5 -
ATACTCTGACTTGTCCCCCAGG-3 ,5  -CGGACAAATGC
TGTGCGTTAG-3  and 5 -TAGGGGAGAGGAAGTTGACT
TTCAT-3 ,5  -AACGAGCG-ACAAAGGAAG-3  and
5 -TCAGTAACCCATTCCGCTTG-3 ,5  -TGACAACACTG
GGGTATGGA-3  and 5 -AACAGGGGATCATCCACAAG-
3 ,a n d5  -CGGAGTCAACGGATTTGGTCGTAT-3  and
5 -AGCCTTCTCCATGGTGGTGAAGAC-3 , respectively.
A total 10 μL reaction volume containing 200 ng of
total RNA, 1 μL of RT reaction solution, 0.4 μM of each
primer, 200 μM each dNTP, 1.5 mM MgCl2,5 0m MK C l ,
10 mM Tris-HCl (pH = 8.3) and 1.25 units of Ampli Taq
Gold polymerase (Applied Biosystems) was incubated
at 25◦C for 10 min, transcripted at 48◦C for 30 min,
and terminated by heating at 95◦C for 5 min. PCR was
performed in a 10-μL reaction volume using Kv 1.4 and
Kv 4.1–4.3 gene expression assay kits and a standard
TaqMan Universal PCR master mix with an initial denat-
uralization step at 95◦C for 12 min followed by 50 cycles
of amplication. Each cycle consisted of a denaturalization
step at 94◦C for 30 seconds, an annealing step at 65◦Cf o r
15 seconds, and an elongation step at 72◦C for 15 sec-
onds. The cycles were followed by a ﬁnal elongation step
at 72◦C for 5 min. Concerning the expression of both
Kv 1.4 and Kv 4 family ampliﬁcations were performed
using the technique of an initial denaturalization step
at 95◦C for 2 min, followed by 35 cycles at 94◦Cf o r
15 seconds, 55◦C for 30 seconds, and 72◦C for 15 sec-
onds. The PCR products were then separated on a 1.5%
agarose gel stained with SYBR Green I (InvitrogenTM Life
Technologies Japan Ltd., Tokyo, Japan).
Immunoreactivity
The chests of four anesthetized rats, under artiﬁcial ven-
tilation, were opened widely at the mid-section. The
animals were transcardially perfused with a ﬁxative, con-
sisting of 100 mL of 4% paraformaldehyde in a 0.01 M
phosphate buffer (PB, pH = 7.3) after perfusion with
50 mL heparinized saline in 0.01 M PB. The nodose gan-
glia were removed and stored with the same solution for
1 h; immersed in 4%, 10%, 20%, and 30% sucrose solu-
tions (5 min × 3 times, 1 h, 3 h, and overnight, respec-
tively) and embedded in an O.C.T. compound (Sakura
Finetechnical, Tokyo, Japan); and then frozen. Subse-
quently, they were serially sectioned at a thickness of
10–15 μm on a cryostat (CM3050s, Leica Biosystem, Nus-
sloch GmbH, Nussloch, Germany) to maintain a similar
distribution of cells to be examined. Six serial sections in
NG were washed in PB solution (PBS) for 5 min and non-
speciﬁc immunoreactivity was inhibited by 0.3% Triton
X-100, 8% bovine serum albumin (Wako Pure Chemical
Industries Ltd., Osaka, Japan) and 10% goat serum albu-
min (Wako Pure Chemical Industries Ltd., Osaka, Japan)
in PBS for 60–90 min at room temperature. In order to
demonstrate Kv 1.4 and CA-II, Kv 4.1 and CA-II, Kv 4.2
and CA-II, and Kv 4.3 and CA-II ﬂuorescent double stain-
ings, sections were separately exposed for a period of 2
days to mix the ﬁrst antibody solution with rabbit anti-
Kv 1.4 (1:160, Alomone Labs Ltd., Jerusalem, Israel)
and sheep anti-CA-II polyclonal (1:500, Biogenesis,
USA), rabbit anti-Kv 4.1 (1:160, Alomone Labs Ltd.,
Jerusalem) and sheep anti-CA-II polyclonal (1:500, Bio-
genesis), rabbit anti-Kv 4.2 (1:160, Chemicon) and sheep
anti-CA-II polyclonal (1:500, Biogenesis) and rabbit anti-
Kv 4.3 (1:160, Alomone Labs Ltd., Jerusalem) and sheep
anti-CA-II polyclonal (1:500, Biogenesis) at 4◦C followed
by incubation in a secondary antibody solution with
Alexa
R  
568 goat anti-rabbit IgG (1:1000, Molecular
Probes, Kv 1.4, Kv 4.1–4.3, red, USA) and donkey anti
IgG sheep-FITC (1:1000, CA-II, green, Chemicon) for
24 h at room temperature, respectively. After the sec-
tions were rinsed in PBS (5 min × 2 times), the sam-
ples were mounted using an anti-fade mounting medium
(Molecular Probes). Control experiments were performed
without the ﬁrst antibody. Under control conditions, the
section without the ﬁrst antibody did not show any
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immunoreactivity. We determined whether NG neurons
express Kv 1.4, Kv 4.1–4.3, and CA-II immunoreactivi-
ties by comparison with the background activity for each
antibody. The neurons with the most intense staining af-
ter subtraction of the control reaction were considered
positive. The immunoﬂuorescence was visualized using
the appropriate ﬁlters. Digital images were collected and
stored on a laboratory computer and later analyzed with
Adobe Photoshop ver. 7.0 and a Leica Imaging Analysis
Tool. Confocal images were generated using a Leica TCS
SP laser scanning microscope (Leica, Microsystems CMC
GmbH, Mannheim, Germany).
Results
Effects of AZ on IA
The K+ currents were recorded for medium and small NG
neurons (<35 μm). We initially conﬁrmed both the in-
creased discharge rate and the increased resting mem-
brane potential (RMP) in those neurons, having a re-
sponse to the 1 mM AZ application and showing a slowly
adapting (SA) type. Such neurons were observed in 65%
of the NG neurons (a total of 31) recorded (Figure 1A).
As shown in Figure 1B, we separated the K+ currents ac-
cording to their responses to variations in conditioning
and identiﬁed two distinct components of voltage-gated
K+ currents, such as total outward K+ current and sus-
tained K+ current (IK). The neurons were ﬁrst held at
−60 mV, and were then increased to either −120 mV
(Figure 1B, top and right panel) or −40 mV (Figure 1B,
middle and right panel) for 300 ms (conditioning pre-
pulse potentials, top and bottom left panels). We then de-
polarized the membrane potentials from −120 or −40 mV
to +60 mV in increments of 10 mV. The transient K+ cur-
rent (IA) was obtained by subtracting IK from the total
outward K+ current (Figure 1B, bottom and right panel).
Before the application of 1 mM AZ, Figure 1C (left panel)
showed the control IA. The application of 1 mM AZ de-
creased IA (Figure 1C, middle panel) and 10 min fol-
lowing the end of the application, the decreased IA re-
turned to the control level (Figure 1C, right panel). Such
an inhibitory effect of 1 mM AZ on IA was seen in all
6 NG neurons examined. The peak values for IA before
and after 1 mM AZ application and during recovery were
1.7 ± 0.1 nA, 1.3 ± 0 . 1n A ,a n d1 . 6± 0.1 nA, respec-
tively. In the peak current density–voltage relationship
of IA, the magnitude of decreased IA seen after 1 mM
AZ application was 25.1 ± 5.5% (P < 0.05 vs. control,
n = 6), and 10 min after ending the 1 mM AZ applica-
tion, the IA tended to return to the control level (5.5 ±
1.0% inhibition of control IA, P < 0.05 vs. AZ effect)
(Figure 1D and E). In addition, we examined the effects of
AZ at different concentrations (0.01, 0.1, 1, and 10 mM)
Figure 1 Identiﬁcation of NG neurons and effect of AZ on IA.( A)A c t i o n
potentials at 3T current injection before and after 1 mM AZ application
as well as during recovery period. (B) Typical examples of three outward
voltage-gated K+ currents (total, IK, and IA). IA (a–b) was determined by
subtraction of IK (b) from the total outward K+ current (a). Right panels,
voltage-pulseprotocols(aandb).(C)TypicalchangesinIA before(control)
and after the application of 1 mM AZ as well as during the recovery from
AZ application. (D) Normalized I-V curves of IA were obtained before (◦)
and after (•) 1 mM AZ application as well as during the recovery from
AZ application ( ). (E) Baseline percent inhibition of IA seen after 1 mM
AZ application () as well as during the recovery from AZ application ().
Each column represents the mean ± SEM. (n = 6). ∗Control versus AZ,
#AZ versus Recovery. ∗,# P < 0.05. (F) Summary of AZ (0.01 0.1, 1 and
10 mM)inhibitory effects on IA in other groups ofeight cells.Each column
represents the mean ± SEM. (n = 8). ∗Control versus AZ (0.01, 0.1, 1, and
10 mM), ∗∗AZ (0.01 mM) versus AZ (0.1, 1, and 10 mM), ∗∗∗AZ (0.1 mM)
versus AZ (1 and 10 mM). ∗,∗∗,∗∗∗P < 0.05.
70 CNS Neuroscience & Therapeutics 17 (2011) 66–79 c   2010 Blackwell Publishing LtdS. Matsumoto et al. AZ Has 4-AP-Like Actions
on the IA. As shown in Figure 1F, the application of AZ
concentration-dependently inhibited IA.A ta+60 mV
step pulse, 0.01, 0.1, 1, and 10 mM AZ inhibited 14.7 ±
4.9% (P < 0.05 vs. control), 21.0 ± 3.9% (P < 0.05 vs.
control and 0.01 mM AZ effect), and 29.6 ± 3.2% (P <
0.05 vs. control and 0.01 and 0.1 mM AZ effects), and
27.5 ± 2.4% (P < 0.05 vs. control and 0.01 and 0.1 mM
effects) of the baseline IA, respectively. Furthermore,
AZ application at 1 mM caused a maximal decrease in
the IA.
Effects of AZ and 4-AP on IA
The K+ current recordings were examined before and af-
ter AZ application (1 mM) in the absence and presence
of 4-AP (1 mM). The typical effect of 4-AP (1 mM) on
IA is also shown in Figure 2A. IA was relatively sensi-
tive to 4-AP. The summarized results of the peak cur-
rent density–voltage relationship of IA in the seven cell
are shown in Figure 2B. The IA was signiﬁcantly inhib-
ited by the application of 1 mM 4-AP (47.6 ± 4.8%) only.
To determine whether the AZ (1 mM)-induced inhibition
IA is a subcomponent of the 4-AP (1 mM) effect, we also
examined the changes in IA in response to 1 mM AZ ap-
plication in the absence and presence of 4-AP (1 mM) on
IA in the other group (Figure 2C). After the 1 mM AZ ap-
plication, the IA was reduced. The IA was further reduced
after co-application with 1 mM AZ plus 1 mM 4-AP. The
summarized results of the peak current density–voltage
relationship of IA of seven cells are shown in Figure 2D
Figure 2 Effects of 4-AP on IA in the absence or presence of AZ. (A)T y p i -
calchangesinIA inresponseto1mM4-APapplication.(B)NormalizedI-V
curves of IA were obtained before (◦, control) and after (•)1m M4 - A P
application.(C)TypicalchangesinIA inresponseto1mM4-APapplication
before and after 1 mM AZ in a different cell of another group. (D) Normal-
ized I-V curves of IA before (◦,c o n t r o l )a n da f t e rt h ea p p l i c a t i o no f1m M
4-AP in the absence (•) and presence ( ) of 1 mM AZ in other group.
(E) Baseline percent inhibition of IA seen after 1 mM 4-AP application ()
only as well as co-application of 1 mM AZ and 1 mM 4-AP ()i no t h e r
group. Each column represents the mean ± SEM. (n = 6). ∗Control versus
4-AP, ∗Control versus 4-AP + AZ. ∗P < 0.05. NS, there were no signiﬁcant
differencesintheinhibition(%)IA between4-AP(1mM)andAZ(1mM)plus
4-AP (1 mM).
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and E. At a +60 mV step pulse, IA was signiﬁcantly in-
hibited by the application of 1 mM AZ (26.3 ± 2.9%),
and the subsequent additional application of 1 mM 4-AP
in the presence of 1 mM AZ resulted in a further inhibi-
tion of IA (48.1 ± 5.7%, P < 0.05 relative to the 1 mM
AZ effects). As shown in Figure 2E, in different groups
of the seven respective cells, the magnitude to which IA
was inhibited after application of both AZ (1 mM) and 4-
AP (1 mM) was similar to that after application of 1 mM
4-AP only.
Effects of AZ and α-DTX on IA
Since the maximal concentration of α-DTX to inhibit ID
is 0.1 μM in rat TTX-R TG neurons [16], we used the
same concentration of the D-current blocker. Figure 3A
shows the effect of α-DTX (0.1 μM) on IA. Three min-
utes after the application of 0.1 μM α-DTX, the ID was
inhibited. The application of 0.1 μM α-DTX to seven
cells signiﬁcantly inhibited the IA at a +60 mV step pulse
(Figure 3B). Figure 3C illustrates a typical example of the
Figure 3 Effectsofα-DTXonIA intheabsenceorpresenceofAZ.(A)Typ-
icalchangesinIA inresponseto0.1μMα-DTXapplication.(B)Normalized
I-VcurvesofIA before(◦,control)andafter(•)0.1μMα-DTXapplication.
(C) Typical changes in IA in response to 0.1 μM α-DTX application before
and after 1 mM in a different cell of another group. (D) Normalized I-V
curves of IA before (◦, control) and after the application of 0.1 μM α-DTX
intheabsence(•)andpresence( )of1mMAZinothergroup.(E)Baseline
percent inhibition of IA seen after 0.1 μM α-DTX application ()o n l ya s
well as co-application of 0.1 μM α-DTX and 1 mM AZ () in other group.
Each column represents the mean ± SEM (n = 6). ∗Control versus α-DTX,
∗Control versus α-DTX +AZ. #α-DTX versus α-DTX +AZ. ∗,#P < 0.05.
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effects of application of α-DTX (0.1 μM) in the absence
and presence of AZ (1 mM) on IA in the other group. The
IA was attenuated by application of 0.1 μM α-DTX and
further reduced after the additional application of 0.1 μM
α-DTX and 1 mM AZ (Figure 3D). The summarized re-
sults from two different groups of ﬁve respective cells are
shown in Figure 3E. The magnitude of IA inhibition pro-
v o k e db y0 . 1μM α-DTX only was 27.2 ± 4.5%. The IA in
the other group of seven cells was signiﬁcantly inhibited
by application of 0.1 μM α-DTX only (26.2 ± 4.0%), and
the subsequent additional application of 1 mM AZ caused
a further enhancement of the α-DTX application-induced
IA inhibition (51.1 ± 5.8%). In two different groups with
or without the 1 mM AZ application, the inhibitory effects
of α-DTX on IA were almost the same. This implies that
additional inhibition of IA seen after AZ application in the
presence of α-DTX is not involved in the contribution of
ID.
Effects of AZ and 4-AP on Action Potentials
To determine whether the 1 mM AZ-induced inhibition
of IA modulates the responses of NG neuronal activity,
shown to be those of the SA type, to 3T current injection
(300 pA), we examined changes in the neuronal activity
in response to AZ (1 mM) application in the absence and
presence of 4-AP (1 mM). During the depolarizing step
pulse, as shown in Figure 4A, the NG neuron ﬁred repeat-
edly and this neuron showed a SA type of ﬁring pattern.
AZ application (1 mM) increased the ﬁring rates and in-
creased the RMP level, and the subsequent additional ap-
plication of 1 mM 4-AP further accelerated these two re-
sponses. The results from the seven cells are summarized
in Figure 4B–F. The application of 1 mM AZ effectively
increased the action potential number (2.7 ± 0.6 imp/s
vs. 3.9 ± 0.6 imp/s, P < 0.05, Figure 4B), resulting in the
reduction of the duration of the depolarizing phase of the
action potential (DDP) (7.0 ± 1.2 ms vs. 5.4 ± 1.0 ms,
P < 0.05, Figure 4D), and increased the RMP (−58.3 ±
2.4 mV vs. −48.9 ± 1.7 mV, P < 0.05, Figure 4C). The
AZ-induced increase in the action potential number was
signiﬁcantly potentiated by the additional application of
4-AP (3.9 ± 0.6 imp/s vs. 5.2 ± 1.4 imp/s, P < 0.05, Fig-
ure 4B). The AZ-induced increase in the RMP was signif-
icantly enhanced by the additional application of 1 mM
4-AP (−48.9 ± 1.7 mV vs. −42.9 ± 1.5 mV, P < 0.05,
Figure 4C). Furthermore, the duration of the repolariza-
tion phase of the action potential (DRP) was signiﬁcantly
prolonged by the additional application of 1 mM 4-AP in
the continuous presence of 1 mM AZ (6.2 ± 0.4 ms or
6.6 ± 0.5 ms vs. 8.0 ± 0.4 ms; P < 0.05 vs. control or AZ
effect, Figure 4E). The additional application of 1 mM 4-
AP in the continuous presence of 1 mM AZ signiﬁcantly
increased the duration of the half-amplitude of the action
potential (6.2 ± 0.7 ms or 6.1 ± 0.9 ms vs. 9.0 ± 0.2 ms;
P < 0.05 vs. control or AZ effect, Figure 4F).
The mRNA Expression of Kv 1.4
and the Kv 4 Family
The expression of both Kv 1.4 and the Kv 4 family
(Kv 4.1–4.3) in the adult rat nodose ganglia was exam-
ined using the RT-PCR technique. mRNA was isolated
from the nodose ganglia of six adult rats, and PCR was
performed with the primers described in the Methods sec-
tion. The primers selectively ampliﬁed mRNA fragments
of the expected sizes for Kv 1.4 (b), Kv 4.1 (c), Kv 4.2
(d), Kv 4.3 (e), and GAPDH (f), as shown in Figure 5. The
control sample that lacked the RT enzyme was negative,
indicating that mRNA was not transcribed from genomic
DNA (Figure 5g).
Double Stainings for the Kv 1.4- or the Kv
Family- (Kv 4.1–4.3) and CA-II-Immunoreactive
Neurons
As shown in Figure 6, NG neurons showed immunore-
activity for Kv 1.4 (486/724, 67.1%), Kv 4.1 (449/728,
61.7%), Kv 4.2 (498/758, 65.7%), and Kv 4.3 (462/722,
64.0%). Furthermore, CA-II was co-expressed in neu-
rons immunoreactive for Kv 1.4 (422/486, 86.5%),
Kv 4.1 (404/449, 90.0%), Kv 4.2 (430/498, 86.3%), and
Kv 4.3 (363/462, 78.6%) immunoreactive neurons. In
this study, we classiﬁed NG cell bodies by size as small
(< 30 μm), medium (30–40 μm), and large (>40 μm).
There were few large NG neurons. All small-to-medium
CA-II-immunoreactive neurons were also immunoreac-
tive for both the Kv 1.4 and the Kv 4 family.
Discussion
The present study provides evidence that the effect of
AZ on the K+ current is mediated by the inhibition of
IA without affecting ID in adult rat NG neurons and that
the response was associated with an increase in the ac-
tion potential number via an increase in the RMP as
well as a decrease in the DDP. Furthermore, we obtained
that mRNAs for voltage-gated K+ channels, Kv 1.4 and
Kv 4.1–4.3, were identiﬁed by RT-PCR from rat NG, and
that the immunoreactivity for four respective Kv chan-
nel proteins was co-expressed with that for CA-II. These
results indicate that the excitability of adult rat NG neu-
ronal activity seen after AZ application would occurs as
a result of the inhibition of Kv families (Kv 1.4 and
Kv 4.1–4.3).
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Figure 4 Effects of AZ on the responses of slowly adapting type NG neu-
ronstocurrentinjectionsbeforeandafter4-AP.(A)Actionpotentialswere
inducedbya3Tcurrentinjection(300pA)beforeandafter1mMAZappli-
cationintheabsenceandpresenceof1mM4-AP.Rightpanel,ﬁrstaction
potentials before (control) and after AZ (1 mM) as well as after AZ (1 mM)
plus4-AP(1mM).Changesinthenumberofspikes(B),restingmembrane
potential (C), DDP (D), DRP (E), and duration (F, duration of half-amplitude
ofactionpotential)inresponsetoAZ(1mM)intheabsenceandpresence
of4-AP(1mM).Eachcolumnrepresentsthemean±SEM.(n=6). ∗Control
versusAZ, ∗ControlversusAZ+4-AP. ∗∗AZversusAZ+4-AP. ∗,∗∗P<0.05.
The DRG and TG neurons contain three different
types of K+ currents in varying quantities: IK,I A,a n dI D
[16,17,23,25,32–34]. In rat DRG neurons, Everill et al.
[35] dentiﬁed three different combination of K+ currents
(A, K, and D currents, A and K currents, and K and D
currents) in the population of cells examined. Such a clas-
siﬁcation is very similar to IA,I D,a n dI K, as reported by
McFarlane and Cooper [9] in neonatal rat NG neurons.
A-type Kv channels in sensory neurons involve Kv fam-
ilies, such as Kv 1.4 and Kv 4.1–4.3 [36,37]. The fact
that in the medium-and small-sized (Aδ-a n dC - )n o c i -
ceptive DRG neurons the reduction in Kv 1.4 occurred
after the sciatic nerve injury [36] and that the tempro-
mandibular joint (TMJ) inﬂammation decreased the ex-
pression of Kv 1.4 subunits in Aδ- and C-type TG neu-
rons [38] suggests that homogenetic Kv 1.4 channels are
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Figure 5 Example of mRNA encoding Kv 1.4 and Kv 4 family channel
proteins in adult rat nodose ganglia. Gel electrophoresis of PCR products
obtained from nodose ganglia. a), A nucleotide size ladder in 100 bp
increments. PCR products obtained with the primer for Kv 1.4 (119 bp,
b), Kv 4.1 (467 bp, c), Kv 4.2 (110 bp, d), Kv 4.3 (400 bp, e), and GAPDH
(418 bp, f). Negative control (no reverse transcription, g).
predominant on Aδ- and C-type axons. However, it has
been reported that the mRNA encodings for the Kv 4
family (Kv 4.1–4.3) are present in the rat dorsal root
ganglia [37]. In addition, 4-AP application signiﬁcantly
reduces the latency of ﬁring and increases the action po-
tential number in isolectin B4-positive DRG neurons im-
munoreactive to Kv 1.4 but not to Kv 1.1 and Kv 1.2 sub-
units [37]. Tanimoto et al. [39] demonstrated that small-
diameter Kv 1.4 positive TG neurons also co-expressed
CA-II immunoreactivity. In the present study, the gene
protein expression of four Kv channels (Kv 1.4 and
Kv 4.1–4.3) was found in the nodose ganglia. Further-
more, we found that 80–90% of the CA-II immunore-
active neurons (12–46 μm, in diameter) examined were
also immunoreactive to either Kv 1.4 or the Kv 4 family
of channel proteins. Therefore, it is possible to speculate
that the AZ effect on the CA-II activity of NG neurons
resembles the blocking action of the A-type currents rep-
resented by Kv 1.4 and Kv 4.1–4.3 channel subunits.
Maren [29] demonstrated that a 20 mg/kg dose of AZ
inhibited 99.99% of the CA enzyme. For the applica-
tions of AZ, ranging from 0.01 to 10 mM, the 1 mM
AZ application showed a maximal inhibition of IA.T h e
magnitude of reduced IA was approximately 27% in the
four different groups (AZ at 1 mM, AZ at 0.01–10 mM,
1m M4 - A P +1m MA Z ,a n d0 . 1μM α-DTX+1m MA Z ) .
Figure 6 Immunoﬂuorescence staining of
adult rat nodose ganglion neurons and
histograms showing diameters of cells labeled
with four Kv channel (Kv 1.4, Kv 4.1–4.3) and/or
CA-II antibodies. Scale bars are 20 μm.
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Therefore, it is most likely that the concentration of 1 mM
AZ used reﬂects the inhibition of CA-II activity of adult
rat NG neurons.
The SAR afferent and/or many myelinated ﬁbers are
not activated by capsaicin, a selective agonist of the
transient receptor potential vanilloid type 1 (TRPV1)
receptors [40,41]. This probably implies that capsaicin
may be a useful tool for identifying the soma of SARs.
However, there is evidence that myelinated capsaicin-
sensitive nociceptive lung afferents exist in guinea-pig
lungs [42]. Furthermore, TRPV1 receptors are also ex-
pressed in approximately 30% of myelinated ﬁbers in
the somatic nerve ﬁbers [43]. Sun et al. [44] have re-
cently demonstrated that TRPV1 receptors are expressed
in a small number of aortic baroreceptor afferents, con-
sisting of myelinated ﬁbers. The application of the TRPV1
receptor antagonist, capsazepine, can prevent constric-
tion of human small airways in in vitro experiments
[45,46]. If NG neurons are capsaicin insensitive, this cri-
terion would narrow to identify a class of the neurons
that include SARs. Furthermore, Kwong et al. [42] re-
ported that in electrophysiological studies, gene expres-
sion studies, and immunohistochemical observations, the
tetrodotoxin-resistant (TTX-R) Na+ channels were simi-
larly distributed between NG A-ﬁbers and C-ﬁbers inner-
vating the lungs. The results indicate that some medium-
sized NG neurons are insensitive to TTX. The SARs are
well known to be one of the mechanoreceptors in the
lung. Taken together, the fact that most NG neurons have
unmyelinated ﬁbers or that NG neurons innervate many
viscera other than the airways, it would be difﬁcult to ac-
curately deﬁne whether the NG neurons recorded are the
soma of SARs.
AZ is known to block reabsorption of sodium bicarbon-
ate and to inhibit H+ secretion by the renal tubule [47].
Regarding the cerebral circulation, AZ has a vaso-relaxant
action on the blood vessels [48,49]. The administration of
AZ stimulates large conductance Ca2+-activated K+ (BK)
channels to alter human forearm vascular tone in in vivo
experiments [50], and also prevents vacuolar myopathy
in K+-depleted rats [51]. Furthermore, AZ treatment can
weaken the development of acute mountain sickness, re-
sulting in the renal bicarbonate reabsorption as well as
a decrease in overall hypoxic sensitivity due to the in-
hibition of the carotid chemoreceptor-induced ventila-
tory reﬂex [52,53]. Additionally, abnormal levels of K+
associated with skeletal muscle disorder are observed in
AZ-responsive periodic paralysis [54–56]. From these ob-
servations, it is possible to speculate that the different
pharmacological effects of AZ are due to the ubiquitous
distribution of CA within the body because the enzyme
plays an important role in so many physiological func-
tions [29,57]. Further studies are needed to determine
whether those effects of AZ, as described above, are in-
volved in the one characteristic of the CA inhibitor that
inhibits IA in adult rat NG neurons selectively.
The application of 1 mM 4-AP, which was a concen-
tration (ranging from 0.05 to 50 mM) nearly equal to the
IC50 value in adult rat TTX-R TG neurons [22], caused ap-
proximately 50% inhibition of the IA, irrespective of the
absence and presence of 1 mM AZ. Since the efﬁciency
of AZ on the inhibition of IA was almost the same for all
four of the four different experimental conditions, the 4-
AP (1 mM)-induced IA inhibition could be divided into
AZ-sensitive and AZ-insensitive components. The results
of this study lead us to suggest that after the blockade of
1m MA Zo nI A, the remaining 4-AP-sensitive K+ currents
are still active in medium and small NG neurons.
It has been reported that the D current is different from
IA, showing greater sensitivity to lower concentrations of
α-DTX (0.001–1 μM) and 4-AP (50–500 μM) in DRG and
TG neurons [15,16,23]. Alpha-DTX K+ currents were ex-
pressed by Kv 1.1, Kv 1.2, and Kv 1.6 in adult rat NG
neurons [15]. In adult rat TTX-R TG neurons, maximal
blockade of ID by α-DTX was 0.1 μM [16]. Furthermore,
the selective blockade of ID by α-DTX was 0.01–0.1 μM
in neonatal rat TTX-R NG neurons [15]. Although the ID
has the ability to delay the ﬁring rates after a depolariz-
ing current step and is sensitive to lower concentrations
of α- DTX and 4-AP [14,16], the inhibition of IA evoked
by 0.1 μM α-DTX application was approximately 20%,
irrespective of the absence and presence of 0.5 mM 4-
AP [16]. The present study showed that the inhibition
of IA seen after 0.1 μM α-DTX application was approx-
imately 27%, irrespective of the absence or presence of
1 mM 4-AP. This probably implies that the component
of ID in the NG neurons may be larger than that in the
TG neurons. Furthermore, we obtained evidence that the
additional application of 1 mM AZ signiﬁcantly inhibited
IA to a greater extent than the 0.1 μM α-DTX applica-
tion alone. Considering the fact that IA i nt h ep r e s e n c eo f
0.1 μM α-DTX application was further reduced by addi-
tional application of 1 mM AZ, we speculate that AZ has
the potential to selectively block IA, which is independent
of the effect on ID in adult rat NG neurons.
In current-clamp experiments, 1 mM AZ application
increased the RMP as well as the action potential num-
ber in a slowly adapting (SA) type of NG neurons. The
latter effect was accompanied by a decrease in the DDP,
indicating that the threshold for the ﬁrst action potential
was reduced by AZ application. This enhanced activity of
SA type NG neurons was similarly manifested by increas-
ing the threshold currents required to evoke action po-
tentials in the absence of AZ. The application of both AZ
(1 mM) and 4-AP (1 mM) caused a further increase in the
action potential number, and the response was usually
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associated with an elevation of the RMP in the ﬁrst ac-
tion potential and showed a signiﬁcant increase in either
the duration of the half-amplitude of the action potential
or the DRP. In the study to determine whether there is
a functional difference between IA and IK on the action
potential in TTX-R adult rat TG neurons, irrespective of
the absence and presence of TEA (2 mM, nearly equal to
the IC50 value), the application of 0.5 mM 4-AP (nearly
e q u a lt ot h eI C 50 value) application increased the action
potential number due to the reduction in the DDP. The
response was associated with an elevation of the RMP,
and the approximately 50% inhibition of IA seen after
1 mM 4-AP application was associated with the approx-
imately 17% inhibition of IK [22]. This probably implies
that the prolongation of both the half-amplitude duration
a n dt h eD R Pa f t e rt h ea p p l i c a t i o no fA Z( 1m M )c o m -
bined with 1 mM 4-AP occurred as a result of the strong
inhibition of IA, partly involving the TEA-like effect. The
fact that the RMPs were different across the depolarizing
step pulses in the case of the AZ and/or 4-AP applications
does not completely rule out the possibility concerning
the contributions of either the gating probability or the
voltage-dependence of TTX-sensitive (TTX-S) Na+ chan-
nels. Further studies are needed to clarify the effect on
the TTX-S Na+ current in adult rat NG neurons. When
considering the results of this study, taken together, it is
conceivable that changes in action potential properties in
response to 1 mM 4-AP application may consist of AZ
(1 mM)-sensitive and -insensitive effects.
In conclusion, our results have demonstrated that the
external application of 1 mM AZ in isolated NG neurons
can decrease IA. In addition, this decrease may be me-
diated by the inhibition of IA, consisting of Kv 1.4 and
Kv 4.1–4.3 channel subunits, but not by the inhibition of
ID. Finally, AZ has the effects of enhancing the intrinsic
ﬁring rates of the action potential in rat NG neurons of
both small and medium sizes.
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